According to Bristol-Myers Squibb's latest financial reports the company has a price-to-book ratio of 4.29.
The price-to-book ratio is a way to measure how much the stock market thinks a company is worth compared to how much the company says its assets are worth on paper.
Year | P/B ratio | Change |
---|---|---|
2022-12-31 | 4.92 | 27.9% |
2021-12-31 | 3.84 | 3.88% |
2020-12-31 | 3.70 | 33.76% |
2019-12-31 | 2.77 | -53.7% |
2018-12-31 | 5.98 | -29.42% |
2017-12-31 | 8.47 | 41.7% |
2016-12-31 | 5.97 | -24.58% |
2015-12-31 | 7.92 | 21.64% |
2014-12-31 | 6.51 | 13.76% |
2013-12-31 | 5.72 | 46.97% |
2012-12-31 | 3.90 | 3.5% |
2011-12-31 | 3.76 | 30.82% |
2010-12-31 | 2.88 | -1.43% |
2009-12-31 | 2.92 | -22.38% |
2008-12-31 | 3.76 | -24.14% |
2007-12-31 | 4.96 | -4.1% |
2006-12-31 | 5.17 | 28.81% |
2005-12-31 | 4.01 | -17.94% |
2004-12-31 | 4.89 | -13.76% |
2003-12-31 | 5.67 | 12.42% |
2002-12-31 | 5.04 |
Company | P/B ratio | differencediff. | Country |
---|---|---|---|
![]() Johnson & Johnson JNJ | 5.36 | 24.94% | ๐บ๐ธ USA |
![]() Novartis NVS | 4.00 | -6.73% | ๐จ๐ญ Switzerland |
![]() Pfizer PFE | 2.29 | -46.68% | ๐บ๐ธ USA |
![]() AbbVie ABBV | 13.9 | 224.49% | ๐บ๐ธ USA |
![]() Eli Lilly LLY | 36.7 | 754.26% | ๐บ๐ธ USA |
![]() Amgen AMGN | 22.1 | 414.90% | ๐บ๐ธ USA |
![]() Sanofi SNY | 1.59 | -63.03% | ๐ซ๐ท France |
![]() Biogen BIIB | 3.20 | -25.44% | ๐บ๐ธ USA |
![]() Merck MRK | 5.98 | 39.37% | ๐บ๐ธ USA |
![]() AstraZeneca AZN | 6.35 | 47.81% | ๐ฌ๐ง UK |